Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES), comprehensive genetic analysis by next-generation sequencing of 480 patients

  • Borràs, Nina
  • Batlle, Javier|||0000-0002-7931-2546
  • Pérez-Rodríguez, Almudena
  • López-Fernández, María Fernanda
  • Rodríguez-Trillo, Ángela
  • Lourés, Esther
  • Cid, Ana Rosa
  • Bonanad, Santiago|||0000-0002-8390-8211
  • Cabrera, Noelia
  • Moret, Andrés
  • Parra, Rafael
  • Mingot-Castellano, María Eva|||0000-0001-9083-855X
  • Balda, Ignacia
  • Altisent, Carmen
  • Pérez-Montes, Rocío
  • Fisac, Rosa María
  • Iruín, Gemma
  • Herrero, Sonia
  • Soto, Inmaculada
  • de Rueda, Beatriz
  • Jiménez-Yuste, Víctor|||0000-0003-3937-3499
  • Alonso, Nieves
  • Vilariño, Dolores
  • Arija, Olga
  • Campos, Rosa
  • Paloma, María José
  • Bermejo, Nuria
  • Berrueco, Rubén|||0000-0002-1068-7489
  • Mateo, Jose|||0000-0002-4227-3256
  • Arribalzaga, Karmele
  • Marco, Pascual
  • Palomo Bravo, Ángeles
  • Sarmiento, Lizheidy
  • Iñigo, Belén
  • Nieto Hernández, Maria del Mar
  • Vidal, Rosa
  • Martínez, María Paz
  • Aguinaco, Reyes
  • César, Jesús María
  • Ferreiro, María
  • García-Frade, Javier
  • Rodríguez-Huerta, Ana María
  • Cuesta, Jorge
  • Rodríguez-González, Ramón
  • García-Candel, Faustino|||0000-0002-6369-6004
  • Cornudella, Rosa
  • Aguilar Franco, Carlos
  • Vidal, Francisco|||0000-0001-8089-4945
  • Corrales Insa, Irene|||0000-0002-0647-0340
Molecular diagnosis of patients with von Willebrand disease is pending in most populations due to the complexity and high cost of conventional molecular analyses. The need for molecular and clinical characterization of von Willebrand disease in Spain prompted the creation of a multicenter project (PCM-EVW-ES) that resulted in the largest prospective cohort study of patients with all types of von Willebrand disease. Molecular analysis of relevant regions of the VWF, including intronic and promoter regions, was achieved in the 556 individuals recruited via the development of a simple, innovative, relatively low-cost protocol based on microfluidic technology and next-generation sequencing. A total of 704 variants (237 different) were identified along VWF, 155 of which had not been previously recorded in the international mutation database. The potential pathogenic effect of these variants was assessed by in silico analysis. Furthermore, four short tandem repeats were analyzed in order to evaluate the ancestral origin of recurrent mutations. The outcome of genetic analysis allowed for the reclassification of 110 patients, identification of 37 asymptomatic carriers (important for genetic counseling) and re-inclusion of 43 patients previously excluded by phenotyping results. In total, 480 patients were definitively diagnosed. Candidate mutations were identified in all patients except 13 type 1 von Willebrand disease, yielding a high genotype-phenotype correlation. Our data reinforce the capital importance and usefulness of genetics in von Willebrand disease diagnostics. The progressive implementation of molecular study as the first-line test for routine diagnosis of this condition will lead to increasingly more personalized and effective care for this patient population.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Unraveling the effect of silent, intronic and missense mutations on VWF splicing, contribution of next generation sequencing in the study of mRNA

  • Borràs, Nina
  • Orriols, Gerard|||0000-0002-1138-5909
  • Batlle, Javier|||0000-0002-7931-2546
  • Pérez-Rodríguez, Almudena
  • Fidalgo, Teresa|||0000-0003-4495-4431
  • Martinho, Patrícia
  • López-Fernández, María Fernanda
  • Rodríguez-Trillo, Ángela
  • Lourés, Esther
  • Parra, Rafael
  • Altisent, Carmen
  • Cid, Ana Rosa
  • Bonanad, Santiago|||0000-0002-8390-8211
  • Cabrera, Noelia
  • Moret, Andrés
  • Mingot-Castellano, María Eva|||0000-0001-9083-855X
  • Navarro, Nira
  • Pérez-Montes, Rocío
  • Marcellin, Sally
  • Moreto, Ana
  • Herrero, Sonia
  • Soto, Inmaculada
  • Fernández Mosteirín, Núria
  • Jiménez-Yuste, Víctor|||0000-0003-3937-3499
  • Alonso, Nieves
  • de Andrés Jacob, Aurora
  • Fontanes, Emilia
  • Campos, Rosa
  • Paloma, María José
  • Bermejo, Nuria
  • Berrueco, Rubén|||0000-0002-1068-7489
  • Mateo, Jose|||0000-0002-4227-3256
  • Arribalzaga, Karmele
  • Marco, Pascual
  • Palomo Bravo, Ángeles
  • Quismondo, Nerea Castro
  • Iñigo, Belén
  • Nieto Hernández, Maria del Mar
  • Vidal, Rosa
  • Martínez, María Paz
  • Aguinaco, Reyes
  • Tenorio, Jesús María
  • Ferreiro, María
  • García-Frade, Javier
  • Rodríguez-Huerta, Ana María
  • Cuesta, Jorge
  • Rodríguez-González, Ramón
  • García-Candel, Faustino|||0000-0002-6369-6004
  • Dobón, Manuela
  • Aguilar Franco, Carlos
  • Vidal, Francisco|||0000-0001-8089-4945
  • Corrales Insa, Irene|||0000-0002-0647-0340
Large studies in von Willebrand disease patients, including Spanish and Portuguese registries, led to the identification of.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis, Lessons from the PCM-EVW-ES Spanish project

  • Pérez-Rodríguez, Almudena
  • Batlle, Javier|||0000-0002-7931-2546
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Borràs, Nina
  • Rodríguez-Trillo, Ángela
  • Lourés, Esther
  • Cid, Ana Rosa
  • Bonanad, Santiago|||0000-0002-8390-8211
  • Cabrera, Noelia
  • Moret, Andrés
  • Parra, Rafael
  • Mingot-Castellano, María Eva|||0000-0001-9083-855X
  • Navarro, Nira
  • Altisent, Carmen
  • Pérez-Montes, Rocío
  • Marcellini, Shally
  • Moreto, Ana
  • Herrero, Sonia
  • Soto, Inmaculada
  • Fernández Mosteirín, Núria
  • Jiménez-Yuste, Víctor|||0000-0003-3937-3499
  • Alonso, Nieves
  • de Andrés Jacob, Aurora
  • Fontanes, Emilia
  • Campos, Rosa
  • Paloma, María José
  • Bermejo, Nuria
  • Berrueco, Rubén|||0000-0002-1068-7489
  • Mateo, Jose|||0000-0002-4227-3256
  • Arribalzaga, Karmele
  • Marco, Pascual
  • Palomo Bravo, Ángeles
  • Castro Quismondo, Nerea
  • Iñigo, Belén
  • Nieto Hernández, Maria del Mar
  • Vidal, Rosa
  • Martínez, María Paz
  • Aguinaco, Reyes
  • Tenorio Núñez, María Concepción
  • Ferreiro, María
  • García-Frade, Javier
  • Rodríguez-Huerta, Ana María
  • Cuesta, Jorge
  • Rodríguez-González, Ramón
  • García-Candel, Faustino|||0000-0002-6369-6004
  • Dobón, Manuela
  • Aguilar Franco, Carlos
  • Batlle, Fernando
  • Vidal, Francisco|||0000-0001-8089-4945
  • López-Fernández, María Fernanda
The multimeric analysis (MA) of plasma von Willebrand factor (VWF) evaluates structural integrity and helps in the diagnosis of von Willebrand disease (VWD). This assay is a matter of controversy, being considered by some investigators cumbersome and only slightly informative. The centralised study 'Molecular and Clinical Profile of von Willebrand Disease in Spain (PCM-EVW-ES)' has been carried out by including the phenotypic assessment and the genetic analysis by next generation sequencing (NGS) of the VWF gene (VWF). The aim of the present study was to evaluate the role of MA to the diagnosis of these patients and their potential discrepancies. Two hundred and seventy out of 480 patients centrally diagnosed with VWD had normal multimers, 168 had abnormal multimers and 42 a total absence of multimers. VWF MA was of great significance in the diagnosis of 83 patients (17.3%), it was also of help in the diagnosis achieved in 365 additional patients (76%) and was not informative in 32 cases (6.7%). With regard to discrepancies, 110 out of 480 (23%) patients centrally diagnosed with VWD presented some kind of discordance between VWF:RCo/VWF:Ag and/or VWF:CB/VWF:Ag ratios, multimeric study and/or genetic results. The VWF MA was key in the presence of novel mutations as well as in cases with phenotypic discrepancies. A comparison between the contribution of MA and VWF:CB showed a clearly higher contribution of the former in the diagnostic process. These data seem to reinforce the relevance of the VWF MA in VWD diagnosis, despite all its limitations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis

  • Martin-Fernandez, Laura|||0000-0002-8909-508X
  • Gavidia-Bovadilla, Giovana
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Brunel, Helena|||0000-0002-1036-7928
  • Ramírez, Lorena
  • López, Sonia|||0000-0002-5023-5153
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Vidal, Francisco|||0000-0001-8089-4945
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Venous thromboembolism is a complex disease with a high heritability. There are significant associations among Factor XI (FXI) levels and SNPs in the KNG1 and F11 loci. Our aim was to identify the genetic variation of KNG1 and F11 that might account for the variability of FXI levels. The KNG1 and F11 loci were sequenced completely in 110 unrelated individuals from the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia 2) Project using Next Generation Sequencing on an Illumina MiSeq. The GAIT-2 Project is a study of 935 individuals in 35 extended Spanish families selected through a proband with idiopathic thrombophilia. Among the 110 individuals, a subset of 40 individuals was chosen as a discovery sample for identifying variants. A total of 762 genetic variants were detected. Several significant associations were established among common variants and low-frequency variants sets in KNG1 and F11 with FXI levels using the PLINK and SKAT packages. Among these associations, those of rs710446 and five low-frequency variant sets in KNG1 with FXI level variation were significant after multiple testing correction and permutation. Also, two putative pathogenic mutations related to high and low FXI levels were identified by data filtering and in silico predictions. This study of KNG1 and F11 loci should help to understand the connection between genotypic variation and variation in FXI levels. The functional genetic variants should be useful as markers of thromboembolic risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease

  • Martin-Fernandez, Laura|||0000-0002-8909-508X
  • Marco, Pascual
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Pérez, Raquel
  • Ramírez, Lorena
  • López, Sonia|||0000-0002-5023-5153
  • Vidal, Francisco|||0000-0001-8089-4945
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
Although plasminogen is a key protein in fibrinolysis and several mutations in the plasminogen gene (PLG) have been identified that result in plasminogen deficiency, there are conflicting reports to associate it with the risk of thrombosis. Our aim was to unravel the genetic architecture of PLG in families with plasminogen deficiency and its relationship with spontaneous thrombotic events in these families. A total of 13 individuals from 4 families were recruited. Their genetic risk profile of thromboembolism was characterized using the Thrombo inCode kit. Only one family presented genetic risk of thromboembolism (homozygous carrier of F12 rs1801020 and F13A1 rs5985). The whole PLG was tested using Next Generation Sequencing (NGS) and 5 putative pathogenic mutations were found (after in silico predictions) and associated with plasminogen deficiency. Although we can not find genetic risk factors of thrombosis in 3 of 4 families, even the mutations associated with plasminogen deficiency do not cosegregated with thrombosis, we can not exclude plasminogen deficiency as a susceptibility risk factor for thrombosis, since thrombosis is a multifactorial and complex disease where unknown genetic risk factors, in addition to plasminogen deficiency, within these families may explain the thrombotic tendency.